Literature DB >> 21854230

V(D)J recombination: mechanisms of initiation.

David G Schatz1, Patrick C Swanson.   

Abstract

V(D)J recombination assembles immunoglobulin and T cell receptor genes during lymphocyte development through a series of carefully orchestrated DNA breakage and rejoining events. DNA cleavage requires a series of protein-DNA complexes containing the RAG1 and RAG2 proteins and recombination signals that flank the recombining gene segments. In this review, we discuss recent advances in our understanding of the function and domain organization of the RAG proteins, the composition and structure of RAG-DNA complexes, and the pathways that lead to the formation of these complexes. We also consider the functional significance of RAG-mediated histone recognition and ubiquitin ligase activities, and the role played by RAG in ensuring proper repair of DNA breaks made during V(D)J recombination. Finally, we propose a model for the formation of RAG-DNA complexes that involves anchoring of RAG1 at the recombination signal nonamer and RAG2-dependent surveillance of adjoining DNA for suitable spacer and heptamer sequences.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21854230     DOI: 10.1146/annurev-genet-110410-132552

Source DB:  PubMed          Journal:  Annu Rev Genet        ISSN: 0066-4197            Impact factor:   16.830


  236 in total

1.  Mechanistic basis for RAG discrimination between recombination sites and the off-target sites of human lymphomas.

Authors:  Noriko Shimazaki; Amjad Askary; Patrick C Swanson; Michael R Lieber
Journal:  Mol Cell Biol       Date:  2011-11-07       Impact factor: 4.272

Review 2.  Evolutionary impact of transposable elements on genomic diversity and lineage-specific innovation in vertebrates.

Authors:  Ian A Warren; Magali Naville; Domitille Chalopin; Perrine Levin; Chloé Suzanne Berger; Delphine Galiana; Jean-Nicolas Volff
Journal:  Chromosome Res       Date:  2015-09       Impact factor: 5.239

3.  RAG1 targeting in the genome is dominated by chromatin interactions mediated by the non-core regions of RAG1 and RAG2.

Authors:  Yaakov Maman; Grace Teng; Rashu Seth; Steven H Kleinstein; David G Schatz
Journal:  Nucleic Acids Res       Date:  2016-07-19       Impact factor: 16.971

4.  RAG2's acidic hinge restricts repair-pathway choice and promotes genomic stability.

Authors:  Marc A Coussens; Rebecca L Wendland; Ludovic Deriano; Cory R Lindsay; Suzzette M Arnal; David B Roth
Journal:  Cell Rep       Date:  2013-08-29       Impact factor: 9.423

Review 5.  Single-cell sequencing-based technologies will revolutionize whole-organism science.

Authors:  Ehud Shapiro; Tamir Biezuner; Sten Linnarsson
Journal:  Nat Rev Genet       Date:  2013-07-30       Impact factor: 53.242

6.  VprBP Is Required for Efficient Editing and Selection of Igκ+ B Cells, but Is Dispensable for Igλ+ and Marginal Zone B Cell Maturation and Selection.

Authors:  Victoria L Palmer; Razia Aziz-Seible; Michele D Kassmeier; Mary Rothermund; Greg A Perry; Patrick C Swanson
Journal:  J Immunol       Date:  2015-07-06       Impact factor: 5.422

Review 7.  Histone methylation and V(D)J recombination.

Authors:  Noriko Shimazaki; Michael R Lieber
Journal:  Int J Hematol       Date:  2014-07-25       Impact factor: 2.490

8.  Peripheral subnuclear positioning suppresses Tcrb recombination and segregates Tcrb alleles from RAG2.

Authors:  Elizabeth A W Chan; Grace Teng; Elizabeth Corbett; Kingshuk Roy Choudhury; Craig H Bassing; David G Schatz; Michael S Krangel
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-11       Impact factor: 11.205

9.  Contribution of V(H) replacement products to the generation of anti-HIV antibodies.

Authors:  Hongyan Liao; Jun-tao Guo; Miles D Lange; Run Fan; Michael Zemlin; Kaihong Su; Yongjun Guan; Zhixin Zhang
Journal:  Clin Immunol       Date:  2012-11-15       Impact factor: 3.969

10.  Illegitimate RAG-mediated recombination events are involved in IKZF1 Δ3-6 deletion in BCR-ABL1 lymphoblastic leukaemia.

Authors:  Y Dong; F Liu; C Wu; S Li; X Zhao; P Zhang; J Jiao; X Yu; Y Ji; M Zhang
Journal:  Clin Exp Immunol       Date:  2016-07-28       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.